Anthony Martinelli is founder and Editor-in-Chief of The Marijuana Herald. Anthony previously served as Editor-in-Chief of TheJointBlog.com (a cannabis news site he founded in 2011 and sold in 2019), and he has worked as a campaign manager and communications director for multiple political campaigns and elected officials. Anthony can be reached at Info@TheMarijuanaHerald.com.
Anthony Martinelli
Author's posts
New York Bill Filed to Require Annual Audits of Office of Cannabis Management
A bipartisan bill filed yesterday in the New York Assembly would require annual audits of the Office of Cannabis Management, adding a new layer of oversight to the agency responsible for regulating the state’s marijuana industry.
Aerobic Exercise Linked to Reduced Migraines and Changes in Endocannabinoid Levels, Study Finds
A randomized clinical trial published in Cannabis and Cannabinoid Research found that regular aerobic exercise may significantly reduce migraine frequency while also altering levels of anandamide, a key endocannabinoid tied to pain and mood regulation.
U.S. Congress: Bipartisan Hemp Bill to Delay New Restrictions Now Has 36 Sponsors
Bipartisan and bicameral legislation in the U.S. Congress that would delay federal hemp restrictions set to take effect this November now has 36 sponsors.
Indiana Governor Says State Will Likely Have to Address Marijuana Legalization as Four Neighboring States Allow It
Indiana Governor Mike Braun said today that the state will likely have to confront the issue of marijuana legalization, offering one of his clearest signs yet that he’s open to some form of reform as pressure builds from surrounding states.
New York Senate Advances Bill to Recognize Out-of-State Medical Marijuana Patients
A New York bill that would recognize out-of-state medical marijuana patients and require regulators to approve pre-roll products in the state’s medical program has now cleared another hurdle in the Senate.
Study Finds Cannabinoids May Help Protect Cognitive Function in Parkinson’s Disease
A study published today in Neuroscience by researchers from the Russian Academy of Sciences finds that cannabinoid-based treatments may have potential to help preserve cognitive function in people with Parkinson’s disease.
Oklahoma Issues Mandatory Recall for Marijuana Products Tested by Greenleaf Labs
The Oklahoma Medical Marijuana Authority has issued a mandatory recall for medical marijuana products tested by Greenleaf Labs between April 2023 and July 2025, escalating an issue the agency says has remained unresolved for months.
Medicare CBD Program Will Allow Some THC, Report Says
A new federal pilot program tied to Medicare will allow certain CBD products to contain small amounts of THC, according to a report first published by Cannabis Wire.
Tilray Medical Expands Australia Portfolio With New Marijuana Flower, Vapes, Extracts and Pastilles
Tilray Medical announced Thursday that it is rolling out its largest expansion in Australia to date, adding a wider range of medical marijuana products as it deepens its presence in one of the world’s more established regulated cannabis markets.
Bipartisan Bill Would Allow Marijuana Companies to List on Nasdaq, NYSE and Expand Financial Protections
A bipartisan bill introduced in the U.S. House would allow marijuana businesses to access major national stock exchanges while also shielding a wide range of companies that provide services to the legal marijuana industry.
Sponsored
